Acquiring Company
Tempus AI
Acquired Company
Personalis
ChicagoMenlo ParkOtherBiotechnologyBiotechnologyHealth CareGeneticsHealth DiagnosticsBioinformaticsDescription
Tempus AI has agreed to acquire Personalis for $1.5 billion. Despite interest from multiple bidders, Personalis opted for Tempus due to antitrust concerns over higher offers. The acquisition is expected to close successfully according to analysts.
Fundz sees it the moment Tempus AI makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Personalis?
Personalis was acquired by Tempus AI, based in Chicago. The deal was reported on October 6, 2026. Tempus AI, Inc. is a leader in artificial intelligence and precision medicine. Tempus AI is publicly traded (TEM) and operates in Other.
When did Tempus AI acquire Personalis?
Tempus AI's acquisition of Personalis was reported on October 6, 2026. Tempus AI has agreed to acquire Personalis for $1.5 billion. Despite interest from multiple bidders, Personalis opted for Tempus due to antitrust concerns over higher offers. The acquisition is expected to close successfully according to analysts. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Personalis do?
Personalis, Inc. (NASDAQ: PSNL) is a company focused on transforming the active management of cancer through personalized testing, guiding care from diagnosis through treatment. It is publicly traded (PSNL), operating in Biotechnology, and is based in Menlo Park.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.